Latest Commercialization News

Swift TV has gained final Netflix approval after a multi-year certification, becoming Australia’s sole enterprise Connective TV platform with direct Google Play Store access. This integration bolsters its foothold in sectors demanding seamless consumer streaming with robust enterprise controls.

REA Group delivered robust Q3 FY26 results, driven by double-digit revenue growth in Australia and record engagement on realestate.com.au, while lowering its cost growth guidance for FY26.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

Amaero Ltd is set to re-domicile from Australia to Delaware via court-approved schemes, issuing US HoldCo CHESS Depositary Interests to shareholders while maintaining its ASX listing. The move aims to tap into deeper US capital markets and enhance strategic growth opportunities.

Proteomics International Laboratories (ASX:PIQ) has denied any undisclosed material information following a sharp share price drop and heightened trading activity, pointing instead to recent strategic updates and organisational changes.

Amplitude Energy has received the VIC/L37 production licence for its Annie gas field, setting the stage for first gas in 2028 to supply Australia's east coast market.

Orbital Corporation has landed a key US order for five 150HFE heavy fuel engines, setting the stage for a lucrative Power by the Hour service model tied to a major US Coast Guard ISR program.

Locate Technologies reveals phased deployment plan for its Locate2u platform under a new three-year FedEx Australia contract, highlighting strategic potential despite uncertain financial impact.

Unith Ltd (ASX:UNT) posted Q3 FY2026 revenue of A$1.26 million, secured a $2 million finance facility to fuel commercial expansion, and showcased significant advancements in its AI Digital Humans platform, including proprietary streaming technology and SDK launches.

Neuren Pharmaceuticals saw a 20% jump in Q1 2026 DAYBUE net sales to US$101 million, with royalties up 23%. The Japan trofinetide trial has been fast-tracked, and the new powder formulation DAYBUE STIX gains early traction.

Hawk Resources has clinched a Mineral Exploration Agreement with Ngaanyatjarrra Traditional Owners for its Olympus Scandium Project, clearing a key hurdle ahead of planned Q2 2026 exploration. Historical data points to a significant scandium anomaly that could define a new province in Western Australia.

BPH Global inks binding deal with Temasek Innovation Holdings to validate its seaweed-based male vitality product through targeted biological assays, advancing regulatory and commercial ambitions.